Table of Contents

• What is Choriogonadotropin Alfa?
• Medical Uses
• How It’s Administered
• Effectiveness
• Potential Side Effects
• Ongoing Research

What is Choriogonadotropin Alfa?

Choriogonadotropin alfa is a synthetic hormone medication that mimics the effects of human chorionic gonadotropin (hCG) in the body. It is also known by the brand names Ovidrel and Ovitrelle^[1]. This medication is a recombinant form of hCG, meaning it is produced in a laboratory using genetic engineering techniques rather than being extracted from human urine like some other hCG products^[2].

Choriogonadotropin alfa belongs to a class of drugs called gonadotropins. These hormones play important roles in regulating reproductive functions in both men and women^[3].

Medical Uses

Choriogonadotropin alfa is primarily used in fertility treatments and assisted reproductive technologies. Its main uses include:

• Triggering ovulation: In women undergoing fertility treatments, it is used to stimulate the final maturation and release of eggs from the ovaries^[1].
• Supporting embryo implantation: It may be used after egg retrieval and fertilization to support the early stages of pregnancy^[1].
• Treating infertility in men: In some cases, it can be used to stimulate testosterone production in men with certain types of infertility^[4].

How It’s Administered

Choriogonadotropin alfa is typically administered as a subcutaneous injection (an injection just under the skin). The dosage and timing of administration depend on the specific fertility treatment protocol being used. Common dosages include:

• 250 micrograms (μg) for triggering ovulation in women^[3]
• 385 μg (equivalent to 10,000 International Units) in some protocols^[5]

The medication is usually given as a single dose at a specific time determined by your doctor, often about 24-36 hours before a scheduled egg retrieval procedure^[3].

Effectiveness

Clinical trials have shown that choriogonadotropin alfa is effective for its intended uses in fertility treatments. For example:

• In women undergoing in vitro fertilization (IVF), it effectively triggers final egg maturation, allowing for successful egg retrieval^[3].
• When used as part of a “luteal support” protocol (supporting the early stages of pregnancy), it may improve pregnancy rates in some patients^[1].

However, the overall success of fertility treatments depends on many factors beyond just the use of this medication.

Potential Side Effects

While choriogonadotropin alfa is generally well-tolerated, it can cause some side effects. These may include:

• Injection site reactions (redness, pain, or swelling where the medication was injected)
• Headache
• Nausea
• Abdominal pain or bloating

In rare cases, more serious side effects can occur, such as ovarian hyperstimulation syndrome (OHSS). This is a condition where the ovaries become swollen and painful, and it requires immediate medical attention^[6].

Ongoing Research

Researchers continue to study choriogonadotropin alfa to optimize its use in fertility treatments and explore potential new applications. Some areas of ongoing research include:

• Comparing different triggering methods: Studies are looking at the effectiveness of using choriogonadotropin alfa alone versus combining it with other medications for triggering ovulation^[7].
• Use in male infertility: Research is exploring how choriogonadotropin alfa might be used to treat certain types of male infertility^[4].
• Potential neuroprotective effects: Some early research is investigating whether choriogonadotropin alfa, in combination with other medications, might have protective effects in patients who have had a stroke^[5]. However, this is still in very early stages of research and is not an approved use of the medication.